Caracterización molecular del virus de la hepatitis C en Montevideo-Uruguay

Rodney Colina; María Cristina Mogdasy; Juan Cristina; María del Rosario Uriarte

Rodney Colina Universidad de la República, Facultad de Ciencias, Centro de Investigaciones Nucleares. Asociación Española Primera de Socorros Mutuos, Laboratorio de Biología Molecular, Licenciado en Biología
María Cristina Mogdasy Asociación Española Primera de Socorros Mutuos, Laboratorio de Análisis Clínicos, Jefe Médico y Consultante de Enfermedades Infecciosas, Médico Microbiólogo
Juan Cristina Universidad de la República, Facultad de Ciencias, Centro de Investigaciones Nucleares (CIN), Director. Doctor en Ciencias Biológicas
María del Rosario Uriarte Asociación Española Primera de Socorros Mutuos, Laboratorio de Biología Molecular, Responsable. Investigador de PEDECIBA. Doctor en Ciencias Biológicas

Keywords: HEPACIVIRUS, HEPATITIS C, GENOTYPE, URUGUAY

Abstract

Background. Hepatitis C virus infection appears to be as one of the main problems associated with emerging infectious diseases. VHC has considerably genetic plasticity; since its categorisation, six primary strains (and an increasingly high number of types) associated with treatment responses and the natural progress of the disease have been identified.
Objectives. To improve diagnosis and follow up for patients with VHC, and to broad epidemiological knowledge using molecular analysis in determining genotype and viral charge.
Methods. We analysed samples of 175 patients with VHC infectious disease referred from March 1997 to June 2001. All patients underwent ELISA, immunoblot and amplification of VHC through reverse transcription and polymerase chain reaction (RT-PCR). Genotype and viral charge were determined in a sub-sample of patients positive for PCR.
Results. Viremia was found in 125 out of 175 patients (173 positive serology for VHC and 2 negative serology for VHC). Analysis of restriction polymorphism (RFLP’s) and nucleotide sequence in 51 chronic carriers showed the following distribution of genotypes and types:
a) genotype 1: 35 cases [type 1a (17), 1b (16), variants (Mon1 and Mon2)]; b) genotype 2: 3 cases [(type 2ª (1) and 2b (2)], and c) genotype 3: 13 cases [type 3a (13)].
Conclusions. Molecular techniques applied to diagnosis and follow up of patients with HVC infectious disease showed to be a new, specific and highly precise tool. Trough automatic sequential ordering and the subsequent philological analysis two HCV variants have been described. They were been entered at the Gen-Bank as Mon 1 and Mon 2. As there was not been found any association between infectious genotype and viral charge, viremia was genotypically non-dependent.

References

1) European Association for the Study of the Liver. International Consensus Conference on Hepatitis C. Consensus statement. J Hepatol 1999; 31: 3-8.
2) Sociedad Uruguaya de Gastroenterología. Consenso Nacional de Hepatitis C. Montevideo: 2001. Rev Med Uruguay 2002 (en prensa).
3) Chao QL, Kuo G, Weiner AJ, Overby LR, Brodery DW, Houghton M. Isolation of a cDNA clone derived from a blood non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
4) Bukh J, Miller RH, Purcell R. Genetic heterogeneity of hepatitis C virus quasispecies and genotypes. Semin Liver Dis 1995; 15: 41-63.
5) Lau JY, Davis GL, Prescott LE, Maertens KL, Lindsay K, Simminds P, et al. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Ann Intern Med 1996; 124: 868-76.
6) Dusheiko GM, Simmons P. Sequence variability of hepatitis C virus and its clinical relevance. J Viral Hep 1994; 1: 1-13.
7) Simmons P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, et al. A proposed system for a nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 1321-4.
8) Manns MP, Wedemeyer H. Hepatitis C Infection - Optimizing Treatment, Patient Management and Basic Aspects. 36th Annual meeting of the European Association for the Study of the Liver (EASL). Gastroenterology 2001; 3(3): 423-34.
9) McOmish F, Yap PL, Dow BC, Follett AC, Seed AJ, Keller AJ, et al. Geographical distribution of hepatitis C virus genotypes in blood donors an international collaborative survey. J Clin Microbiol 1994; 32: 884-92.
10) Shiratori Y, Kato N, Yokosuka O, Hashimoto E, Hayashi N, Nakamura A, et al. Quantitative assays for hepatitis C virus in serum as predictors of the long-term response to interferon. J Hepatol 1997; 27: 437-44.
11) Chan SW, McOmish F, Holmes EC, Dow B, Peutherer JF, Follett E, et al. Analysis of a new hepatitis C type and its phylogenetic relationship to existing variants. J Gen Virol 1992; 73: 1131-41.
12) Murphy D, Willems B, Delage G. Use of 5’ non-coding region for genotyping hepatitis C virus. J Infec Dis 1994; 169: 473-5.
13) Davidson F, Simmons P, Ferguson JC, Jarvis LM, Dow BC, Follett AC, et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5’ non-coding region. J Gen Virol 1995; 76: 1197-1204.
14) Higgins DG, Thompson JD, Gibson TJ. Using clustal for multiple sequence alignments. Methods Enzimol 1996; 266: 383-402.
15) Felsenstein L. Phylogeny inference packgae, version 3.5. Seattle: Department of Genetics. University of Washington, 1993.
16) Kumar U, Monjiardino J, Thomas HC. Mega: Molecular Evolutionary Genetic Analysis for microcomputers. Comput Appl Biosc 1994; 10: 189-91.
17) Zeuzem S, Lee JH, Franke A, Ruster B, Prummer O, Herrmann W, et al. Quantification of initial decline of serum hepatitis C RNA and response to interferon alfa. Hepatology 1998; 27: 1149-56.
18) Colina RH, Uriarte MR, Mogdasy C, Azambuja CJ, Cristina JC. Evidence of genetic diversification in isolates of Hepatitis C virus. J Gen Virol 1999; 80: 1377-82.
19) Vega I, Colina R, García L, Uriarte MR, Mogdasy C, Cristina J. Diversification of Hepatitis C Viruses in South America reveals a novel genetic lineage. Arch Virol 2001; 146: 1626-9.
20) Thomas DL, Stanley M. Hepatitis C. In: Mandell G, Bennett J, Dolin R. Principles and Practice of Intectious Diseases, 5a ed. New York: Churchil Livingstone, 2000: 1736-176.
21) Nakao T, Enomoto N, Takada A, Date T. Typing of hepatitis C virus (HCV) genomes by restriction fragments lenght polymorphisms. J Gen Virol 1992; 72: 2105-12.
22) Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Pershing DH. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Ann Intern Med 1996; 125: 634-9.
23) McCaw R, Moaven L, Locarnini SA, Bowden DS. Hepatitis C virus genotypes in Australia. J Viral Hepat 1997; 4: 351-7.
24) Puyol FH, Loureiro CL, Devesa M, et al. Determination of genotypes of hepatitis C in Venezuela by restriction fragment length polymorphism. J Clin Microbiol 1997; 35: 1870-2.
25) Oubina JR, Quarleri JF, Rudzinski M, Parks C, Badia I, Gonzalez-Cappa SM. Genomic characterization of hepatitis C virus isolates from Argentina. J Med Virol 1995; 47: 97-104.
26) Picchio GR, Nakatsuno M, Boggiano C, et al. Hepatitis C (HCV) genotype and viral titter distribution among Argentinean hemophilic patients in the presence or absence of human inmunodeficiency virus (HIV). J Med Virol 1997; 52: 219-25.
27) Krug LP, Lunge VR, Ikuta N, et al. Hepatitis C virus genotypes in Southern Brasil. Braz J Med Res 1996; 29: 1629-3.
28) Kanistanon D, Neelamek M, Dharakul T, Songsivilai S. Genotypes distribution of hepatitis C virus in different regions of Thailand. J Clin Microbiol 1997; 35: 1772-6.
29) Russi J, Gadola L, Verdaguer C, Labella M, Chiparelli H, Alonso G, et al. Serotipificación de virus de Hepatitis C en pacientes en Hemodiálisis. Rev Nefrol 1998; 18: 227.

Molecular characterization of Hepatitis C virus in Montevideo, Uruguay

Abstract

References

Follow on Twitter